Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.50 |
| ▸ | DPP4 | P27487 | 2/20 | 0.49 |
| ▸ | SORD | Q00796 | 2/20 | 0.47 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.45 |
| ▸ | HTR2C | P28335 | 1/20 | 0.44 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.41 |
| ▸ | ACACB | O00763 | 1/20 | 0.39 |
| ▸ | MALT1 | Q9UDY8 | 1/20 | 0.39 |
| ▸ | PHGDH | O43175 | 1/20 | 0.39 |
| ▸ | DRD2 | P14416 | 2/20 | 0.38 |
| ▸ | DRD3 | P35462 | 1/20 | 0.38 |
| ▸ | RPLP1 | P05386 | 1/20 | 0.38 |
| ▸ | RPLP0 | P05388 | 1/20 | 0.38 |
| ▸ | RPS17 | P08708 | 1/20 | 0.38 |
| ▸ | RPSA | P08865 | 1/20 | 0.38 |
| ▸ | RPS2 | P15880 | 1/20 | 0.38 |
| ▸ | RPL35A | P18077 | 1/20 | 0.38 |
| ▸ | RPL7 | P18124 | 1/20 | 0.38 |
| ▸ | RPL17 | P18621 | 1/20 | 0.38 |
| ▸ | RPS4Y1 | P22090 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17844940 | 1.00 | HRH4 (0.50) | HRH4DPP4SORDHCAR2HTR2C | |
| SCHEMBL17844915 | 0.78 | DPP4 (0.52) | HRH4DPP4SORDHCAR2HTR2C | |
| SCHEMBL17861369 | 0.78 | HRH4 (0.48) | HRH4DPP4SORDHCAR2HTR2C | |
| SCHEMBL17844939 | 0.76 | HRH4 (0.59) | HRH4DPP4SORDHCAR2HTR2C | |
| SCHEMBL17844941 | 0.76 | HRH4 (0.59) | HRH4DPP4SORDHCAR2HTR2C | |
| SCHEMBL17861370 | 0.76 | HRH4 (0.59) | HRH4DPP4SORDHCAR2HTR2C | |
| SCHEMBL1728700 | 0.74 | HRH4 (0.54) | HRH4DPP4SORDHCAR2HTR2C | |
| SCHEMBL19753765 | 0.73 | HRH4 (0.53) | HRH4DPP4SORDHCAR2HTR2C | |
| SCHEMBL17847581 | 0.72 | DPP4 (0.49) | HRH4DPP4SORDHCAR2HTR2C | |
| SCHEMBL17865226 | 0.72 | PDE10A (0.49) | HRH4DPP4HCAR2MALT1DRD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3233827-B1 | ANTIBACTERIAL COMPOUNDS HAVING BROAD SPECTRUM OF ACTIVITY | ACRAF (IT) | 2020-07-08 | — | — | EP | disclosed |
| US-10221144-B2 | Antibacterial compounds having broad spectrum of activity | AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. (IT) | 2019-03-05 | — | — | US | disclosed |
| US-20170369450-A1 | ANTIBACTERIAL COMPOUNDS HAVING BROAD SPECTRUM OF ACTIVITY | AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. (IT) | 2017-12-28 | — | — | US | disclosed |
| EP-3233827-A1 | ANTIBACTERIAL COMPOUNDS HAVING BROAD SPECTRUM OF ACTIVITY | Aziende Chimiche Riunite Angelini Francesco A.C.R. (IT) | 2017-10-25 | — | — | EP | disclosed |
| WO-2016096686-A1 | ANTIBACTERIAL COMPOUNDS HAVING BROAD SPECTRUM OF ACTIVITY | AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. (IT) | 2016-06-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170369450-A1 | ANTIBACTERIAL COMPOUNDS HAVING BROAD SPECTRUM OF ACTIVITY | MRPL21, ABCG2, CLPP | HRH4 3875/4885DPP4 23/4885SORD 2344/4885 |
| US-10221144-B2 | Antibacterial compounds having broad spectrum of activity | MRPL21, ABCG2, CLPP | HRH4 3875/4885DPP4 23/4885SORD 2344/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.